Kenya Administers HIV Prevention Drug

Kenya to offer patients free six-month HIV 'breakthrough' prevention jab

Kenya's health authorities have begun administering lenacapavir, a long-acting HIV prevention drug delivered by injection that offers protection for six months. The treatment will be available free of charge to eligible patients, making Kenya one of the first countries to introduce this new prevention therapy.

Kenya administers HIV prevention drug

In tonight's programme, DR Congo forces launched drone strikes on M23 rebels near Rubaya, a key coltan mine, as militias capture Kazinga. Also, Kenya begins administering its first doses of LENACAPAVIR, a groundbreaking, long-acting HIV prevention drug. And, the tastes of Africa are on full display at the Paris Agricultural Fair - including Sudan, showcasing its unique flavours despite the devastation of war.

Kenya rolls out twice-yearly HIV prevention shot in Nairobi slum

Kenya began administering the first doses of lenacapavir—a groundbreaking twice-yearly HIV prevention injection—in a Nairobi slum on Thursday, offering new hope in the country's fight against the virus.

Kenya Launches Long-Acting HIV Prevention Drug Lenacapavir

Nairobi -- Kenya has officially launched Lenacapavir, a groundbreaking long-acting injectable for HIV prevention, marking a major step in strengthening the country's response to the epidemic.

Kawangare delivery man becomes first person to use long-acting HIV prevention injection, Lenacapavir

Samson Mutua, 27, is the first Kenyan to receive Lenacapavir, a long-acting HIV prevention injection, marking a significant milestone in Kenya's health initiatives.